Condition
Malignant Pleural Effusion|Lung Cancer|Mesothelioma|Breast Cancer|Ovarian Cancer
Estimated Enrollment: 19
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: MpeTK01
Study First Received: November 19, 2013
Last Updated: December 30, 2016
Estimated Primary Completion Date: December 2015
Primary Outcome Measures:
Safety|Progression-free survival|Overall survival
Sponsors and Collaborators:
Advantagene, Inc.|University of Pennsylvania
Website Link: https://ClinicalTrials.gov/show/NCT01997190
